中国农业科学院特产研究所(简称特产所)建于 1956 年,是全国唯一的专门从事特种经济动植物资源保护、开发与利用的国家级综合性农业科研机构,也是中国农科院在吉林省的唯一直属单位,主要研究对象为珍贵、稀有、经济价值高的特种经济动植物。
本所构建了分工清晰、运转高效的组织体系,下设创新团队、支撑部门、职能部门与所办企业四大板块,其中创新团队主攻科研攻关,支撑部门提供技术保障,职能部门负责行政管理,所办企业推动成果转化。
本所持续完善科研创新体系,稳步建设各级科研平台,聚力开展特种经济动植物领域基础研究与技术攻关,为产业发展提供坚实科技支撑,全面提升核心科研竞争力。
本所聚焦特种经济动植物资源保护、开发与利用,统筹承担乡村振兴、科技帮扶、知识产权管理等任务。以智慧农业、绿色低碳、宠物经济三大协同创新中心为核心抓手,重点推进成果转化、示范推广与科企协同,加速产业化项目共建落地,以科技赋能特色产业高质量发展。
特产学会与特种经济动物兽医分会搭建行业学术交流网络,《特产研究》《特种经济动植物》专注刊载特种经济动植物科研成果,汇聚科研力量,传播前沿技术,为产业发展搭建高水平学术阵地。
充分发挥专家团队、科研平台与科研资源优势,现已构建起涵盖博士、学术硕士、留学生及专业学位研究生的多层次人才培养体系。
作者:Chen Bai, Yue Zhang, Xiaohui Huo, Huifang Liu, Jiyue Sha , Yinshi Sun , Jianbo Chen
刊物名称:Journal of Ginseng Research
发表年月:January 2026
摘要内容:Background: Allergic rhinitis (AR) is a non infectious chronic inflammatory disease of nasal mucosa mediated by IgE and driven by type 2 immune response. Ginsenoside Rg5 (Rg5) is a bioactive compound derived from ginseng, but its effect on AR is unknown. Objective: This study investigated the therapeutic potential of Rg5 in toluene diisocyanate (TDI)-induced AR and explored its potential mechanism involving JAK2/SATAT3/BCL-2 and MAPK signaling pathways as well as nasal microbiota regulation. Methods: AR model was established by TDI sensitization and different doses of Rg5 were administered to assess symptom scores, IgE, His and cytokine levels. Nasal mucosal tissues and lung tissues were analyzed histopathologically for key proteins in the JAK2/STAT3/BCL-2 and MAPK pathways in the nasal mucosa. Nasal microbiota composition was assessed using 16S rRNA sequencing and signaling pathway correlation analysis was performed. Results: Rg5 significantly reduces IgE, His, and pro-inflammatory factors, increases anti-inflammatory factors, mitigates damage to the nasal mucosa and lung tissues, thereby alleviates nasal symptoms. It suppresses the activation of JAK2/STAT3 and MAPK pathways and upregulates BCL-2 expression. It also increases the abundance of Actinobacteria and Acidobacteria, decreases that of Bacteroidetes and Desulfobacteria, and restores the diversity of nasal microbiota. Rg5 ameliorates AR symptoms by enriching beneficial bacteria (e.g., Campylobacterota, Patescibacteria, and Acidobacteriota), regulating cytokine levels, and synergistically modulating the JAK2/STAT3/BCL-2 and MAPK pathways. Conclusion: Ginsenoside Rg5 acts synergistically through the JAK2/STAT3/BCL-2 and MAPK signaling pathways while restoring nasal microbiota homeostasis and attenuating TDI-induced AR symptoms, highlighting its potential as a novel therapeutic agent for AR.

人参皂苷Rg5显著减少了大鼠的过敏性鼻炎的症状
原文链接:DOI: 10.1016/j.jgr.2026.100984.